ELAINE KIM: Open Payments
NPI 1144536400 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 37 payments from 19 companies in 2025. Trend: 2023 $2,009 · 2024 $2,041 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $316 |
| Amgen Inc. | 5 | $183 |
| Novartis Pharmaceuticals Corporation | 7 | $172 |
| E.R. Squibb & Sons, L.L.C. | 2 | $154 |
| Alnylam Pharmaceuticals Inc. | 2 | $139 |
| Novo Nordisk Inc | 3 | $137 |
| HEARTFLOW, INC. | 1 | $129 |
| ABIOMED | 1 | $123 |
| PFIZER INC. | 2 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $103 |
Products named: INSPIRE, REPATHA, LEQVIO, CAMZYOS, FFRct, AMVUTTRA, VYNDAQEL, JARDIANCE.
Industry payments across TX — which companies pay providers there.
